HCW Biologics Inc. (HCWB) NASDAQ
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
HCW Biologics Inc.
Address
2929 North Commerce Parkway
Miramar, FL 33025
United States of America (the)
Phone
954 842 2024
Website
Sector
Healthcare
Industry
Biotechnology
Employees
35
First IPO Date
July 20, 2021
Key Executives
| Name | Title | Pay | Year Born |
| Hing C. Wong | Founder, Chief Executive Officer, Director & Secretary | 438,656 | 1954 |
| Peter Rhode | Chief Scientific Officer & Vice President of Clinical Operations | 263,895 | 1958 |
| Rebecca Byam | Chief Financial Officer | 309,308 | 1956 |
| Lee D. Flowers | Senior Vice President of Business Development | 0 | 1946 |
| Nicole Valdivieso | Vice President of Legal Affairs | 0 | N/A |
Description
HCW Biologics Inc. operates as a preclinical-stage biopharmaceutical firm, primarily engaged in the discovery and advancement of novel immunotherapies. Its research and development efforts are focused on addressing chronic, low-grade inflammation and a spectrum of age-related diseases. The company's leading therapeutic candidates include HCW9218, an injectable immunotherapeutic designed for patients with a variety of cancers, such as pancreatic, ovarian, breast, prostate, and colorectal, as well as for pulmonary fibrosis. Another key product, HCW9302, targets autoimmune conditions like alopecia areata and various metabolic disorders. Beyond these, HCW Biologics is also developing HCW9201, a cell-based therapy currently in Phase II clinical trials for the treatment of relapsed/refractory acute myeloid leukemia. Additionally, HCW9206 is under development specifically for acute myeloid leukemia. Incorporated in 2018, the company's corporate headquarters are situated in Miramar, Florida.
